|Application ||WB, FC, E|
|Other Accession||P41564, Q58CP0|
|Calculated MW||42794 Da|
|Antigen Region||366-393 aa|
|Other Names||Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial, Isocitric dehydrogenase subunit gamma, NAD(+)-specific ICDH subunit gamma, IDH3G|
|Target/Specificity||This IDH3G antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 366-393 amino acids from the C-terminal region of human IDH3G.|
|Precautions||IDH3G Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia.
Bzymek, K.P., et al. Biochemistry 46(18):5391-5397(2007)
Soundar, S., et al. J. Biol. Chem. 281(30):21073-21081(2006)
Simpson, J.C., et al. EMBO Rep. 1(3):287-292(2000)
Weiss, C., et al. Biochemistry 39(7):1807-1816(2000)
If you have any additional inquiries please email technical services at email@example.com.